Business Wire

PHILIP-MORRIS-INT

4.2.2020 10:38:09 CET | Business Wire | Press release

Share
Philip Morris International Recognized by CDP as a Global Leader in Sustainable Action

Philip Morris International Inc. (PMI) (NYSE: PM) has once again been recognized as a global leader in sustainability performance and disclosure by CDP—an international nonprofit that collects data to help decision-makers reduce risk, capitalize on opportunities and drive action toward a more sustainable world. In CDP’s most recent rankings, PMI earned a position on the prestigious Water Security A List, recognizing the company as a global leader in water security. PMI has also been placed on CDP’s Supplier Engagement Leaderboard, designating it as a global leader in engaging with its suppliers on climate change, and has achieved a ranking of A- for its Forest disclosure.

Last month, PMI also ranked—for the sixth year in a row—on CDP’s A List for climate change , recognizing PMI’s work to reduce its environmental impacts, end to end, in the midst of its historic transformation toward a smoke-free future. The company has been recognized for its actions and strategies to reduce emissions and manage climate risks in its supply chain in the past reporting year. PMI’s sustainable commitments have also been documented as part of the 50 Sustainability and Climate Leaders initiative.

“Being recognized by CDP for our sustainability efforts is both humbling and encouraging as we continue our transformation,” said Huub Savelkouls, PMI’s Chief Sustainability Officer. “Our work toward achieving a smoke-free future isn’t just about transforming our product, it’s also about completely transforming the value chain and keeping sustainability at the heart of everything we do. We intend to accelerate our efforts for even greater impact.”

PMI’s water strategy accounts for the risks it faces—including from natural disasters, water scarcity and agricultural supply chain instability—and drives action toward responsible use of water as a shared resource, taking into consideration the needs of local communities. As PMI increases its manufacturing capacity for smoke-free products—which requires more water than for cigarettes—the company is evolving its water strategy, with clean technology investments enabling water savings and water recycling. One example of this is PMI’s implementation of the Alliance for Water Stewardship (AWS) standard. In 2017, PMI became a member of AWS; just one year later, it certified its first manufacturing site, in Brazil, to the AWS standard. Five additional PMI factories were AWS certified in 2019, and the company is making good progress toward its goal of certifying all factories by 2025.

In addressing the A List companies, Paul Simpson, CEO of CDP, said: “Congratulations to the companies that achieved a position on CDP’s A List this year, for leading in environmental performance and transparency. The scale of the business risks from the climate emergency, deforestation and water insecurity are vast—as are the opportunities from addressing them—and it’s clear the private sector has a vital role to play at this critical time. The A List companies are leading the market in corporate sustainability, tackling environmental risks and setting themselves up to thrive in tomorrow’s economy.”

This year also marks the third consecutive year CDP has recognized PMI as a leader in supplier engagement. With more than 36,000 contracted suppliers, PMI’s total supply chain has a significant environmental, social and economic footprint that calls for comprehensive programs to address risks and achieve improvements. These programs have earned the company the distinction of being among the top 3 percent of organizations assessed by CDP, with PMI now included among the fewer than 160 companies on the Leaderboard.

With regard to combating deforestation, PMI has developed a zero deforestation manifesto and aims to have a net positive impact on forests associated with its tobacco supply chain by 2025. Additionally, as part of PMI’s Good Agricultural Practices , the company’s tobacco suppliers are expected to prevent biodiversity loss.

“Our commitment to a smoke-free future has enabled us to make significant strides in our transformation into a more sustainable company,” said Laurence Ruffieux, PMI’s Director of Operation Sustainability. “We’ve given great attention to the roles that water, forest and supplier engagement play within our value chain and are honored to be recognized by the CDP for our work here. The CDP recognition energizes us to further focus our efforts to mitigate climate change, and the scoring process will continue to inspire us and guide our progress.”

A global environmental impact nonprofit, CDP provides a framework of action through which companies can measure and manage environmental risks and opportunities, transparently report on progress and commit to corporate sustainability initiatives. The full methodology and criteria for the Climate Change, Water Security, and Forest evaluations are available here on CDP’s website.

Additional information about PMI’s sustainability actions and commitments are available in the company’s annual Sustainability Report and on PMI.com/Sustainability .

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the United States. In addition, PMI ships a version of its IQOS Platform 1 device and its consumables authorized by the U.S. Food and Drug Administration to Altria Group, Inc. for sale in the United States under license. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI’s smoke-free IQOS product portfolio includes heat-not-burn and nicotine-containing vapor products. As of Sept. 30, 2019, PMI estimates that approximately 8.8 million adult smokers around the world have already stopped smoking and switched to PMI’s heat-not-burn product, available for sale in 51 markets in key cities or nationwide under the IQOS brand. For more information, please visit www.pmi.com and www.pmiscience.com .

About CDP

CDP is a global nonprofit that drives companies and governments to reduce their greenhouse gas emissions, safeguard water resources and protect forests. Voted number one climate research provider by investors and working with institutional investors with assets of US$96 trillion, we leverage investor and buyer power to motivate companies to disclose and manage their environmental impacts. Over 8,400 companies with over 50% of global market capitalization disclosed environmental data through CDP in 2019. This is in addition to the over 920 cities, states and regions who disclosed, making CDP’s platform one of the richest sources of information globally on how companies and governments are driving environmental change. CDP is a founding member of the We Mean Business Coalition. Visit https://cdp.net/en or follow us @CDP to find out more.

###

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye